Judit Liaño Pons

Our paper is out! @karolinskainst @JournalofExper1

Check out our recent review on Neuroblastoma, in which we discuss the cell of origin, current treatment protocols, and the precision medicine strategies under development, including metabolism, induction of differentiation, and immunotherapy. academic.oup.com/neuro-oncology…

Reflecting on the Stockholm MYC Conference we hosted at @karolinskainst a few weeks ago. Amazing talks, discussions, and shared insights will pave the way for advancements in MYC biology and treatment. #MYCResearch

A druggable conformational switch in the c-MYC transactivation domain nature.com/articles/s4146…

Available postdoc position in our lab ki.varbi.com/en/what:job/jo…

@Luc1Sky @LeonLaboratorio @IBBTEC @oncogenejournal Congrats!!!👏🏻👏🏻👏🏻

💥Just released!! 👇🏼 This is how MYC promotes EBV infection in Burkitt's lymphoma 👌🏻🦠🦀 @LeonLaboratorio @ibbtec @oncogenejournal nature.com/articles/s4138…

Do you want to contribute to top quality medical research? 🔬 We are offering a postdoctoral position in generation of a novel mouse model for neuroblastoma based on human induced pluripotent stem (iPS) cells.🧫 ki.varbi.com/en/what:job/jo…

Do you want to contribute to top quality medical research? 🔬 We are offering a postdoctoral position in identification of novel metabolic targets and differentiation inducing agents in cancer.🧬 ki.varbi.com/en/what:job/jo…

Las científicas e investigadoras Berta Casar y Judit Liaño contaron su experiencia como científicas al alumnado de 1ºESO dentro del programa #conocelas2023 #iesvillajunco @casar_lab @Judiitlp1

Gracias @ies_villajunco por dejarme compartir mi experiencia como científica con las nuevas generaciones! #CONOCELAS2023 #ASEICAmujer @ASEICAnews

Marie Arsenian-Henriksson and colleagues show that a combination therapy that activates three nuclear hormone receptors (GR, ERα and RARα) leads to neural differentiation, metabolic reprogramming and reduced tumour burden in neuroblastoma #MTCPubs jeccr.biomedcentral.com/articles/10.11…

In this review, Marie Arsenian Henriksson and colleagues discuss the potential of mitochondria as a target for precision medicine in cancer, presenting current inhibitors and challenges, and highlighting those enzymes that are attractive targets. #MTCPubs nature.com/articles/s4141…

Great talks, discussions and excitement for this emerging field of #ferroptosis, in the beautiful Awaji island, Japan. Thanks @CSHANews!

Thank you everyone for your participation in #CSHAsia meeting on #Iron, #ROS & #Ferroptosis in Life, Death & Disease at #Awaji Japan. You guys are awesome! We truly believe this community will continue to grow. Come back again in Asia for CSH Asia meetings. Until next time!😉

@ABallestinR @EU_Commission @MSCActions @institut_curie @GiorgioSeano @vanRheenen_Lab @NKI_nl Big congrats!!! :D

New adventures coming! I have obtained the competitive contract Marie Skłodowska-Curie Postdoctoral Fellowship (MSCA-PF). It's possibly the most prestigious contract in the European Union for a postdoctoral researcher. 🧵1/3

New! 💣 Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in #neuroblastoma Full text 👇 jeccr.biomedcentral.com/articles/10.11… #MetabolicReprogramming #Estrogenreceptor @IREISGufficiale

Today in partnership with @emblebi, we’re releasing predicted structures for nearly all catalogued proteins known to science, which will expand the #AlphaFold database by over 200x - from nearly 1 million to 200+ million structures: dpmd.ai/AF-22-TW 1/

Surface proteins may reverse the development of malignant neuroblastoma cells, show a KI-study by Marie Arsenian-Henriksson and others in @JournalofExper1 #childhoodcancer #neuroblastoma news.ki.se/activated-surf…

Do you want to know more about the potential of mitochondria as a target for precision medicine in cancer? Check out our recent review published in @cddpress @SpringerNature @karolinskainst nature.com/articles/s4141…